Literature DB >> 22974782

Image-guided ablative therapies for lung cancer.

Amita Sharma1, Fereidoun Abtin, Jo-Anne O Shepard.   

Abstract

Lung cancer is the commonest cause of death in adults. Although the treatment of choice is surgical resection with lobectomy, many patients are nonsurgical candidates because of medical comorbidities. Patients may also have recurrent disease after resection or radiotherapy and some patients refuse surgical options. Image-guided ablation has been recently introduced as a safe, alternative treatment of localized disease in carefully selected patients. This article discusses the principles, technique, and follow-up of the 3 main ablative therapies currently used in the lung, radiofrequency ablation, microwave ablation, and percutaneous cryotherapy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22974782     DOI: 10.1016/j.rcl.2012.06.004

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  12 in total

1.  eComment. Standardizing our cooking.

Authors:  Calvin S H Ng; Rainbow W H Lau; Kelvin K W Lau
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01

Review 2.  Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.

Authors:  Guy C Jones; Jason D Kehrer; Jenna Kahn; Bobby N Koneru; Ram Narayan; Tarita O Thomas; Kevin Camphausen; Minesh P Mehta; Aradhana Kaushal
Journal:  Clin Lung Cancer       Date:  2015-04-23       Impact factor: 4.785

3.  Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?

Authors:  Rameses Sroufe; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 4.  Cancer concepts and principles: primer for the interventional oncologist-part II.

Authors:  Ryan Hickey; Michael Vouche; Daniel Y Sze; Elias Hohlastos; Jeremy Collins; Todd Schirmang; Khairuddin Memon; Robert K Ryu; Kent Sato; Richard Chen; Ramona Gupta; Scott Resnick; James Carr; Howard B Chrisman; Albert A Nemcek; Robert L Vogelzang; Robert J Lewandowski; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2013-06-28       Impact factor: 3.464

5.  Enhancing therapeutic efficacy through designed aggregation of nanoparticles.

Authors:  Tanmoy Sadhukha; Timothy S Wiedmann; Jayanth Panyam
Journal:  Biomaterials       Date:  2014-06-16       Impact factor: 12.479

6.  Targeted percutaneous microwave ablation at the pulmonary lesion combined with mediastinal radiotherapy with or without concurrent chemotherapy in locally advanced non-small cell lung cancer evaluation in a randomized comparison study.

Authors:  Xinglu Xu; Xin Ye; Gang Liu; Tingping Zhang
Journal:  Med Oncol       Date:  2015-08-05       Impact factor: 3.064

7.  Radiotherapy dose calculation on KV cone-beam CT image for lung tumor using the CIRS calibration.

Authors:  Changsheng Ma; Jianping Cao; Yong Yin; Jian Zhu
Journal:  Thorac Cancer       Date:  2014-01-02       Impact factor: 3.500

Review 8.  Use of cryoablation beyond the prostate.

Authors:  Saim Yılmaz; Mustafa Özdoğan; Metin Cevener; Ali Ozluk; Aysegul Kargi; Feride Kendiroglu; Irfan Ogretmen; Akin Yildiz
Journal:  Insights Imaging       Date:  2016-01-13

Review 9.  Irreversible electroporation: state of the art.

Authors:  Peter Gk Wagstaff; Mara Buijs; Willemien van den Bos; Daniel M de Bruin; Patricia J Zondervan; Jean Jmch de la Rosette; M Pilar Laguna Pes
Journal:  Onco Targets Ther       Date:  2016-04-22       Impact factor: 4.147

10.  Irreversible electroporation for locally advanced pancreatic cancer through a minimally invasive surgery supported by laparoscopic ultrasound.

Authors:  Ernesto Tartaglia; Massimiliano Fabozzi; Antonia Rizzuto; Anna Settembre; Roberta Abete; Ludovica Guerriero; Pasqualino Favoriti; Diego Cuccurullo; Francesco Corcione
Journal:  Int J Surg Case Rep       Date:  2017-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.